58 related articles for article (PubMed ID: 31357875)
1. Different Relationships between F
Högman M; Thornadtsson A; Bröms K; Janson C; Lisspers K; Ställberg B; Hedenström H; Malinovschi A
COPD; 2019 Aug; 16(3-4):227-233. PubMed ID: 31357875
[TBL] [Abstract][Full Text] [Related]
2. Association between fraction of exhaled nitrous oxide, bronchodilator response and inhaled corticosteroid type.
Smith RW; Downey K; Snow N; Dell S; Smith WG
Can Respir J; 2015; 22(3):153-6. PubMed ID: 25874734
[TBL] [Abstract][Full Text] [Related]
3. Role of FeNO in predicting the responsiveness of inhaled corticosteroids in COPD: a systematic review.
Ramesh R; Georgiou A; Harries T
Br J Gen Pract; 2024 Jun; 74(suppl 1):. PubMed ID: 38902064
[TBL] [Abstract][Full Text] [Related]
4. Relationship of Blood Eosinophils with Fractional Exhaled Nitric Oxide and Pulmonary Function Parameters in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation.
Tang B; Huang D; Wang J; Luo LL; Li QG
Med Sci Monit; 2020 Mar; 26():e921182. PubMed ID: 32161254
[TBL] [Abstract][Full Text] [Related]
5. Type-2 inflammation and lung function decline in chronic airway disease in the general population.
Çolak Y; Afzal S; Marott JL; Vestbo J; Nordestgaard BG; Lange P
Thorax; 2024 Mar; 79(4):349-358. PubMed ID: 38195642
[TBL] [Abstract][Full Text] [Related]
6. Reference values of fractional excretion of exhaled nitric oxide among non-smokers and current smokers.
Torén K; Murgia N; Schiöler L; Bake B; Olin AC
BMC Pulm Med; 2017 Aug; 17(1):118. PubMed ID: 28841881
[TBL] [Abstract][Full Text] [Related]
7. [Effects of type 2 inflammation on bronchodilator responsiveness of large and small airways in chronic obstructive pulmonary disease].
Xu G; Gong Z; Wang J; Ma Y; Xu M; Chen M; Hu D; Liang J; Zhao W; Zhao H
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):93-99. PubMed ID: 38293980
[TBL] [Abstract][Full Text] [Related]
8. Domiciliary monitoring of exhaled nitric oxide in the management of asthma: a pilot study.
Li H; Lin J; Zhang Q; Wang J; Li C
BMC Pulm Med; 2024 May; 24(1):244. PubMed ID: 38760654
[TBL] [Abstract][Full Text] [Related]
9. Exhaled nitric oxide levels in COPD patients who use electronic cigarettes.
Higham A; Beech A; Singh D
Nitric Oxide; 2024 Apr; 145():57-59. PubMed ID: 38428515
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-Lymphocyte Ratio and Blood Eosinophil Levels As Inflammatory Indicators in Smoker and Non-smoker Young Adult Patients With Chronic Obstructive Pulmonary Disease at a Tertiary Care Hospital.
Waseem SMA; Masood I; Siddiqui AH; Amir M; Hussain SH; Husaini SHM
Cureus; 2024 Mar; 16(3):e56212. PubMed ID: 38618443
[TBL] [Abstract][Full Text] [Related]
11. Relation between duration of smoking cessation and bronchial inflammation in COPD.
Lapperre TS; Postma DS; Gosman MM; Snoeck-Stroband JB; ten Hacken NH; Hiemstra PS; Timens W; Sterk PJ; Mauad T
Thorax; 2006 Feb; 61(2):115-21. PubMed ID: 16055612
[TBL] [Abstract][Full Text] [Related]
12. The association of blood eosinophil counts and FEV
Hong YS; Park HY; Ryu S; Shin SH; Zhao D; Singh D; Guallar E; Cho J; Chang Y; Lim SY
Eur Respir J; 2024 May; 63(5):. PubMed ID: 38636990
[TBL] [Abstract][Full Text] [Related]
13. Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation.
Silkoff PE; Singh D; FitzGerald JM; Eich A; Ludwig-Sengpiel A; Chupp GC; Backer V; Porsbjerg C; Girodet PO; Dransfield MT; Baribaud F; Susulic VS; Loza MJ
Biomark Insights; 2017; 12():1177271917730306. PubMed ID: 28959121
[TBL] [Abstract][Full Text] [Related]
14. Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers.
Hoonhorst SJ; ten Hacken NH; Vonk JM; Timens W; Hiemstra PS; Lapperre TS; Sterk PJ; Postma DS
PLoS One; 2014; 9(2):e87443. PubMed ID: 24505290
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET.
Alter P; Stoleriu C; Kahnert K; Henke MO; Bals R; Trudzinski FC; Watz H; Speicher T; Söhler S; Welte T; Rabe KF; Wouters EFM; Vogelmeier CF; Jörres RA
Int J Chron Obstruct Pulmon Dis; 2023; 18():2911-2923. PubMed ID: 38084341
[TBL] [Abstract][Full Text] [Related]
16. Exhaled nitric oxide as a biomarker in COPD and related comorbidities.
Malerba M; Radaeli A; Olivini A; Damiani G; Ragnoli B; Montuschi P; Ricciardolo FL
Biomed Res Int; 2014; 2014():271918. PubMed ID: 24719850
[TBL] [Abstract][Full Text] [Related]
17. Effect of shisha (waterpipe) smoking on lung functions and fractional exhaled nitric oxide (FeNO) among Saudi young adult shisha smokers.
Meo SA; AlShehri KA; AlHarbi BB; Barayyan OR; Bawazir AS; Alanazi OA; Al-Zuhair AR
Int J Environ Res Public Health; 2014 Sep; 11(9):9638-48. PubMed ID: 25233010
[TBL] [Abstract][Full Text] [Related]
18. Correlation of fractional exhaled nitric oxide (FeNO) and clinical outcomes in patients with chronic obstructive pulmonary disease: A prospective cohort study.
Keeratichananont W; Kaenmuang P; Geater SL; Denyuk R; Kanchanakanok C
Respir Med; 2024 May; 229():107682. PubMed ID: 38815659
[TBL] [Abstract][Full Text] [Related]
19. Exhaled nitric oxide, eosinophils and current smoking in COPD patients.
Higham A; Beech A; Dean J; Singh D
ERJ Open Res; 2023 Nov; 9(6):. PubMed ID: 38020571
[No Abstract] [Full Text] [Related]
20. Exhaled nitric oxide in stable chronic obstructive pulmonary disease.
Beg MF; Alzoghaibi MA; Abba AA; Habib SS
Ann Thorac Med; 2009 Apr; 4(2):65-70. PubMed ID: 19561927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
